Abbott Laboratories falls on Q1 profit forecast below estimates

** Shares of medical device maker Abbott Laboratories ABT.N fall 2.02% to $114.43 premarket

** Co expects Q1 adj EPS of between $1.05 and $1.09, below estimates of $1.11 - data compiled by LSEG

** Forecasts 2025 adj EPS of $5.05 to $5.25, with midpoint mostly in line with estimates of $5.16

** Q4 adj EPS of $1.34 meets estimates

** Reports Q4 sales of $10.97 bln vs est of $11.01 bln

** Shares rose 2.8% in 2024

(Reporting by Puyaan Singh and Sriparna Roy in Bengaluru)

((Puyaan.Singh@thomsonreuters.com;))